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 Of the entire human genome, 90% of all genetic information is transcribed but only a 
fraction of that subsequent RNA is translated into proteins. RNAs which are not translated into 
proteins are deemed non-coding RNAs.  Little is known about this large category of noncoding 
RNAs, although they perform a variety of functions within the cell.  RNA crystallography is 
used to study RNA tertiary structure, which gives insight to the function of these non-coding 
RNAs. However, complications associated with RNA crystallography arise due to RNA’s lack of 
surface functional group diversity, flexible tertiary structure, and conformational heterogeneity.  
 A novel technique, Chaperone-assisted RNA crystallography (CARC), can greatly 
improve the success in crystallization of RNA. With this technique, synthetic antibodies called 
Antigen Binding Fragments (Fabs) are employed as crystallization chaperones to promote the 
structure elucidation of certain target RNAs.  
 To identify Fabs that complex with RNA molecules of interest, we constructed a 
randomized library of synthetic antibodies enriched in ligand binding regions with tyrosine, 
serine, glycine, and arginine residues. This Fab protein library was constructed with a minimal 
codon design, and then screened against a variety of RNA targets. Several Fabs have been 
identified and isolated through phage display selection against three RNA targets. These Fabs 
were expressed and biochemically characterized for their binding affinities and specificities. To 
date, five Fabs have been identified and they have outstanding capabilities in binding their 
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A Background on Antibody Research and RNA Targeting  
 The development of antibody technologies has led to a wide array of biomedical 
applications including the use of antibodies as research tools, diagnostic agents, and therapeutic 
drugs. Antibodies have been widely employed for protein targeting in assays such as the Western 
Blot and ELISA. They have also been used for therapeutics, and they are currently being 
developed into cancer treatment agents. Other uses of antibodies which target proteins include 
detection of disease antigens and cell surface marker analysis. 
 However a lack of endogenous nucleic acid-binding antibodies has largely restricted their 
use to only proteins. Nucleic acids lack immunogenicity because they get degraded too quickly 
upon entrance into a host by nuclease activity, and the host has no time to develop specific 
antibodies towards that antigen. For these reasons, there is no solid foundation for obtaining 
RNA-binding antibodies. 
 Current sources of antibodies include the derivation of monoclonal antibodies by fusing a 
B cell to an immortal hybriboma cell and producing clones of that hybridoma. These clones all 
secrete identical antibodies to the original fused B cell. Another method for obtaining antibodies 
is harvesting the serum of a host or mammal after injection of the antigen into that host. 
Antibodies specific to the injected antigen can then be purified out of the serum, these are said to 
be a collection of polyclonal antibodies because they were generated from a pool of B cells. Both 
of these methods for obtaining antibodies are expensive and time consuming. Furthermore, these 




 Of the entire human genome, 90% of all genetic information is transcribed but only a 
fraction of that subsequent RNA is translated into proteins. RNAs which are not translated into 
proteins are deemed non-coding RNAs.  Little is known about this large category of noncoding 
RNAs, although they perform a variety of functions within the cell.  Examples of non-coding 
RNAs include rRNA, tRNA, siRNA, and many others. Very little is known about the structure 
and function of this vast array of non-coding RNAs, and better tools to study RAN structure 
must be developed to correct this issue.  
 A novel method has been designed for obtaining RNA-binding synthetic antibodies. This 
method involves designing a randomized antigen binding fragment (Fab) library, screening that 
library with phage display, expressing and purifying the selected Fabs, and characterizing each 
of these Fabs for their RNA-binding potentials (Fig 1). The development of nucleic acid-binding 





























 In past work, Ye et al. designed a Fab library and also developed phage display methods 
to obtain specific RNA-binding Fabs from their Fab library (Fig 1) (1). With the produced 
specific Fabs, the crystal structures of the P4P6 domain as well as the class I ligase were 
elucidated by Chaperone-Assisted RNA crystallography (CARC). This crystallization method 
employs Fabs as crystal chaperones to aid in crystal packing, molecular stability, and obtaining 
initial phasing information from the target Fab-RNA complex.  
However, this Fab library was not initially designed for the targeting of RNA. It was later 
found that the Fabs in this library had low RNA-binding affinities and many Fabs bound to their 
RNA targets via nonspecific interactions (1). Although their developed phage display methods 
were able to isolate the RNA-binding Fabs from their Fab library, it was realized that a Fab 
library specifically for RNA recognition was needed.  
 Designing a RNA-binding Fab library requires vital knowledge in RNA-Fab recognition. 
More specifically, one must know exactly where to install randomized sites on a Fab for the 
design of a Fab library. Additionally, it must be known which residues should be kept constant. 
One must also know what the amino acid composition of those randomized sites should be in 
order to yield a Fab library that specifically targets RNA structures (2,3). The study and analysis 
of Fab-RNA interfaces can lead to the foundational knowledge which is required for the design 
of RNA-specific Fab libraries. By studying the complementarity determining region (CDR) of an 
RNA-specific binding Fab, vital knowledge can be gained. The CDR of each Fab is the region 
which determines complementarity between that Fab and its RNA target. Thus by studying the 
amino acid content of the CDRs of selected Fabs, the active residues that are making RNA-
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specific contacts can be identified. This information can be applied for initial design of other Fab 
libraries that target other tertiary RNA structures. 
 For my project, a minimal amino acid code was used to design a Fab library specific for 
Fab-RNA binding (4). The YSGR minimal codon library of Fab fragments, as it has been called, 
was screened by phage display selection in order to select for Fabs that bind tightly and 
specifically to their RNA targets of interest. Fabs that were isolated from the YSGR minimal 
codon library via initial phage display screening were sequenced and further biochemically 
characterized. Specific RNA-binding Fabs which were selected from the YSGR minimal codon 












Design and Construction of the YSGR Minimal Codon Fab library 
Theory Behind the Minimal Codon Design: Fab structure and the YSGR Minimal Codon Fab 
library 
 The YSGR minimal codon Fab library was designed by engineering randomized point 
mutations into each of the CDRs of the Fab 2 scaffold. Fabs within the YSGR minimal codon 
library were randomized in all three light chain CDRs, as well as all three heavy chain CDRs. As 
a consequence of this minimal amino acid code, variable sites were not randomized with just any 
of the 20 amino acids from the genetic code; they were randomized using only a four amino acid 
genetic code (5).  
 One of four amino acids was inserted into each position of the CDR that was engineered 
to be randomized. This means that each randomized residue on each Fab within the library could 
only be coded into one of four amino acids rather than into one of the usual twenty. This minimal 




 sequence variants. This 
minimal codon design also reduced the gap between the theoretical library size and practical 
library size (6).  
 The four amino acids which were chosen consisted of Tyrosine, Serine, Glycine, and 
Arginine. Tyrosine and serine were chosen because previous crystal structure analysis has shown 
that they both make key RNA-binding interactions (3). While Arginine was chosen for its 
potential to form stabilizing electrostatic interactions with RNA, and Glycine was chosen to 
promote flexibility of the Fab within the CDR (2,3). 
 Each randomized position on the Fab structure had equal potential to be one of any four 
of the designated amino acids. This is a minimal codon Fab library design, as compared to a 
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normal library design where the randomized positions on each Fab would have their normal 
potential to encode for one of any of the 20 amino acids.  
 This project will serve as a challenge to the Fab-RNA interface. It will be tested whether 
or not a minimal code design within a Fab library will be sufficient to obtain tight and specific 
RNA-binding Fabs. It will thus be determined whether or not this minimal codon design will 
yield enough CDR variability to produce specific RNA-binding Fabs from a minimal codon Fab 
library design such as this one.  
Experimental Design and Methods for Library Construction 
 The positions of the Fab to be randomized were selected based on their solvent exposure 
and their potential to interact with the RNA antigen as visualized and analyzed in the 3D crystal 
structure viewer program called PyMol. More specifically, a crystal structure of the complex of 
Fab2 and the P4-P6 RNA Ribozyme Domain was viewed and analyzed in PyMol to identify 
CDR residues that were making specific points of contact with the P4P6 RNA antigen (1). These 
identified interactions were either by direct contact or by water mediated Hydrogen bonds. 
Library construction was also based on analysis of the Fab2 -P4-P6 RNA binding interface (Fig 
2).   
 Each amino acid residue that was chosen to be randomized was then correlated to the 
location of its codon within the corresponding DNA sequence. This correlation was made by the 
Kabat numbering system which was designed for identification of residues within immunologic 
proteins (7). Scaffold residues were chosen to be conserved in all Fabs to maintain each protein’s 
native structural integrity. A Kunkel mutagenesis reaction was employed to effectively mutate 
the CDR sequences of the template into desired randomized sequences (8).  
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Figure 2 Image of the specific synthetic Fab2 bound to the P4P6 Ribozyme 
 
Shown here is an image of Fab2 bound to the P4P6 Ribozyme domain. Various amino acid 
residues (circles) of the Fab 2 are depicted here as making RNA-specific contacts. Randomized 
residues were chosen based on their potential to interact with the RNA antigen and also the level 
of their solvent exposure. For exmaple, shown at the bottom of this image is a group of serine 
residues that are making RNA-specific contacts. These are all examples of residues that should 





 To generate the YSGR minimal codon library, a template DNA strand was first made as a 
starting point for construction. The template strand was made by introducing stop codons into the 
six CDR regions of the P4-P6 Fab2 DNA scaffold through a Kunkel mutagenesis site-specific 
reaction (1). This design prevented the translation of unmutated DNA into Fab proteins (8). 
Then, sixteen library mutagenic primers were designed to engineer the amino acid residues Y, S, 
G, and R into all six CDRs of the heavy chain and light chain with position and length 
variability. Then, oligonucleotides containing these randomizations were ordered and 
synthesized by Integrated DNA Technologies and used as primers in the Kunkel mutagenesis 
reaction. 
 The Kunkel mutagenesis reaction was carried out with the synthesized template DNA and 
the sixteen library mutagenic primers which were ordered. This required a Kunkel mutagenesis 
protocol with an unprecedented number of primers. Thus, the reaction required experimental 
optimization to ensure proper annealing of all 16 primers to the template DNA plasmid. Reaction 
optimizations for temperature, primer-to-template ratio, enzyme concentration, and incubation 
time were all carried out to maximize the reaction yield.  
 The optimized conditions were shown to be: primers phosphorylated at 37°C with 
polynucleotide Kinase 4 for 1 hour, then annealed to the template DNA for 1.5 hours in 37°C. 
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A). This agarose gel confirmed the optimized reaction conditions for the Kunkel reaction. The 
middle lane shows the Kunkel product band in highest yield (middle band). B) This agarose gel 
confirms the ssDNA template which was synthesized as a starting point. A Kunkel mutagenesis 







RNA Targets for Screening Characterization of the YSGR Minimal Codon 
Fab Library 
 To demonstrate the diverse functionality of the YSGR minimal codon Fab library, three 
RNA targets were chosen for Fab library screening. Two of these targets were riboswitches, and 
the third RNA target was a Ribozyme domain.  
Description of Riboswitches and Why They Should be Studied 
 Riboswitches are cis-acting RNA elements that are present in the 5’ untranslated region 
of mRNA where they act to control gene expression posttranscriptionally(9). Abundant in many 
pathogenic organisms, these regulatory RNAs mediate genes essential for life and virulence (10). 
Riboswitches fold to complex tertiary structures by binding to small organic metabolites and 
control gene expression through transcription termination, translation initiation, or alternative 
splicing (11,12). By targeting these riboswitches with novel antibiotics, the pathogen’s ability to 
control gene expression can be disrupted and its virulence can be inactivated (13). Targeting 
novel aspects of bacterial physiology such as the control of gene expression by riboswitches will 
evade the current drug resistance mechanisms used by many human pathogens.   
 The level of antibiotic resistance possessed by pathogenic bacteria and fungi is constantly 
increasing throughout society. This issue presents dangerous implications for the worldwide 
control of pathogenesis, and it must be rectified (14). Antibiotic resistance is increasing by the 
day in our society, and current therapeutics which target very few cellular processes are 
becoming increasingly ineffective. Through the widespread use of these antibiotics and by 
natural selection, antibiotic resistance genes have allowed many pathogenic organisms to 
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overcome these current antibiotic inhibition mechanisms and proliferate in the presence of the 
antibiotics which were originally designed to kill them.  
 My project aims to alleviate the problem of increasing antibiotic resistance through 
contributing to the design of novel drugs that target the glycine riboswitch present in two 
pathogenic species (15) (Fig 4). With the crystal structure of this riboswitch, the detailed 
structural information of the metabolite binding sites can be employed to assist in the structure-
based antibiotic drug design (13). However, riboswitches and RNA in general have a very low 
level of success in crystallization. This is due to a variety of factors such as RNA’s lack of 
surface functional group diversity, flexible tertiary structure, and conformational heterogeneity 
(16).  These issues present major road blocks in the process of crystallization because crystal 
lattice formation is dependent on tight packing of molecules and high stability (16). The unique 
approach employed by my project aims to overcome this issue by forming crystal contacts 
through Fab chaperones. 
 The YSGR Minimal Codon library of Fab Fragments has been synthesized specifically 
for selection against RNA targets. Fabs which were selected via initial screening were then 
expressed as soluble proteins. Biochemical analysis was then carried out on each Fab. This was 
completed to characterize the capability of each Fab to stabilize their RNA target and thus 
promote the crystallization of a Fab-RNA complex via CARC.  
The Three Specific RNA Targets Which Were Chosen for Library Screening  
  Once the YSGR minimal codon Fab library was designed, it was then screened against 
three RNA targets: the Vibrio cholerae glycine riboswitch (VCLDI), the Fusobacterium 
nucleatum glycine riboswitch (FNIII), and the P4P6 ribozyme domain (P4P6). Each of these 
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RNA targets had to be synthesized in order to be used as targets in the screening of the YSGR 
minimal codon Fab library. The P4P6 domain was chosen as a positive target control and allows 
comparison to the selection results with previous previous P4P6 library targeting.  
 Two of these targets are highly conserved glycine riboswitches that are present in the 
vibrio cholerae and fusobacterium nucleatum pathogenic species: the VCLD1 riboswitch, and the 
FNIII riboswitch (Fig 4). In order to design antibiotics which will target the glycine riboswitch in 
these species and others, we must know all possible detailed structural information. The 
metabolite binding sites of the glycine riboswitch must be deduced as this will facilitate in-depth 
structural analysis. Crystallization of the glycine riboswitch will also provide insight on how to 
use novel antibiotics in the targeting of many different riboswitches that are present in several 
bacterial and fungal species.  
Methods and Materials for Construction of the Three RNA Targets for Library Screening 
     The three RNA targets were synthesized by the following experimental methods (Fig 4): 
 Polymerase Chain Reaction: ddH20, 10x pfu buffer , 10 mM dNTPs , template plasmid 
DNA 6ng/ul, 6 uM FWD primer, 6 uM RVS primer, 2.5U/ul pfu. Regular PCR cycle was ran.  
 EcoRI and HindIII double digestion reaction : 10ug PCR product, NEB buffer 2, 15 u/uL 
Eco RI and HindIII. Purified this reaction with Qiagen PCR cleanup kit, measured the DNA 
concentration by UV spectrophotometer.  
 Ligation into digested pUC19 vector: 10ng/ul pUC19 vector, 1 ul double digested gene 
insert, 10x T4 DNA ligase buffer, ddH2O, T4 DNA ligase, 16
o 
C overnight.  
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 50uL of this ligation reaction was then used to do a heat shock transformation into 
competent JM109 strain Escherichia coli cells, then the cells were plated on a LB/Ampicillin 
agar plate.  
 After transformation into JM109 cells, two colonies were picked from the LB/Amp plate 
and inoculated into 4 ml liquid autoclaved LB/Amp media in cell culture tubes; shaken for 12-16 
hrs at 37 
o
C. Combined 750 ul overnight cell culture with 150 ul 80% glycerol, stored at -80 
o
C. 
Spun down the remaining cell cultures in the Allegra X-12R refrigerated tabletop centrifuge for 
10 min at 4 
o
C, ~3500 rpm. Decanted the media into sink and follow the Qiagen miniprep kit to 
extract plasmid. Checked the concentration using 2 ul plasmid (dilute 35x with TE) on UV 
spectrometer.  
 A small scale EarI digestion of harvested plasmid DNA was then completed with NEB 
buffer 4. A 2% agarose gel was run to check the digested product. 500ng of DNA product was 
then sent for sequencing at ETON bio.   
 The correctly sequenced clones were chosen for amplification and harvest of DNA with 
Qiafilter plasmid Midi Kits. The DNA was extracted with PCA solution twice to get rid of 
RNase A in the late steps of the Midiprep Kit . Then, the larger scale EarI digestion of plasimd in 
NEB buffer 4 was completed, followed by in-vitro transcription.  
 RNA purification was carried out as follows: Buffer exchanged into 5 mM Sodium 
Citrate, completed PAGE gel purification, Electroeluted via dialysis in TE Buffer pH 8, PCA 
extracted the RNA, and completed the Ethanol precipitation. Then RNA was redissolved in TE 
Buffer and stored  in -20°C.  
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A) This figure shows a secondary structure prediction for the glycine riboswitch as it exists is the 
FN and VC species. This figure demonstrates the highly conserved genetic nature of the glycine 
riboswitch. B) This agarose gel confirmed the PCR reaction during cloning. C) This agaorse gel 
confirmed the Ear1 digestion reaction after cloning into the expression vector. D) This gel 
confirmed the final cloning step- the in-vitro transcription reaction which produced the RNA 







Initial Screening of the YSGR Minimal Codon Fab Library 
General Process of Initial Screening for the YSGR Minimal Codon Fab Library  
 The YSGR minimal codon Fab library was selected against both the VC and FN 
riboswitches to isolate RNA-binding Fabs, as well as the P4P6 ribozyme domain for comparison 
of library functionality. The method employed to screen this library was called phage display 
selection, and it was followed by phage ELISA (17). This selection process used phage particles 
which displayed each of the Fab proteins containing the randomized CDRs on their surface (Fig 
5) (18). 
 Phage ELISA was subsequently completed to isolate Fabs that proved to bind their RNA 
target (Fig 5). Positive clones were then sent for DNA sequencing to confirm and identify the 
amino acid sequences of each unique Fab clone. The harvested and sequenced DNA for each Fab 













Figure 5 Schematic of Phage Display Selection and Phage ELISA 
A) This schematic shows a phage particle that is currently expressing a Fab as a surface protein 
on its coat (Sachdev Sidhu, Biomolecular Engineering vol. 18 issue 2 Sept. 2001, pages 57-63). 
The Fab is denoted in purple, note that the Fab is open for interactions with other 
Macromolecules. B) This flowchart demonstrates the process used for Phage Display Selection. 
C) This flowchart demonstrates the entire initial screening process in general and what it leads 






Materials and methods for Initial Library Screening: Phage Display Selection, ELISA 
 Phage selection: First, the biotinylated RNA target was incubated with washed magnetic 
streptavidin beads for 15 min at 25°C. Phage particles with Fab proteins expressed on their coats 
were added, and 15 min incubation at 25°C was carried out. The washing was then completed in 
two steps to eliminate the Fabs that did not bind their RNA targets specifically. Fabs which were 
present after washes were then eluted out and amplified via XL1-blue cell culture. This was 
completed by infecting the E.coli cells with the DNA from within phage particles that expressed 
RNA-binding Fabs. Further rounds of selection were then completed with a similar protocol (Fig 
5) (18).  
 Phage display selection has been completed for both the VC and FN riboswitches. 
Additionally, the P4P6 RNA domain was targeted with the YSGR minimal codon Fab library 
through Phage Display Selection to confirm library functionality. The results of Phage Selection 
for the YSGR minimal codon Fab library against all three RNA targets are described under the 
results of initial screening (Table 1). 
 Phage ELISA: 48 colonies were grown from the phage titer. Each colony was inoculated 
into 400 μL 2 YT, Amp, and 10
10
/mL M13KO7 helper phage in 96-well deep-well plate at 
grown 37ºC for 16 hours. All 48 colonies were duplicated on to a LB/ Ampicillin Agar plate with 
a numbered grid for colony retrieval, and the plates  were incubated at 37ºC for 16 hours. 
 Maxisorp plate was then coated with nuetravidin buffer, then blocked with BSA in 1x 
PBS. Columns: 1, 3, 5, 7, 9, 11 were loaded with 100 μL/well 25 nM RNA-ext/biotin (prefolded) 
in RNA binding buffer, and wells: 2,4,6,8,10,12 were loaded with only RNA binding buffer as a 
control. (RNA Folding reaction: 2.5 ul 50 uM RNA-ext/biotin + 97.5 ul RNA binding buffer, 
50ºC for 30mins; room temperature for 10 mins; Add to 4.9 ml RNA binding buffer at RT in a 
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new falcon tube and mix). Then, the 96 deep well plate with cell cultures in each well was 
centrifuged at 3500rpm for 25 mins to pellet. 
 70 uL of supernatant was then transferred from the deep well plate to normal ELISA 
plate. 140 uL of phage dilution solution was then added and mixed with 1.5x RNA binding 
buffer (0.75% BSA, 30 ug/ml sheared salmon DNA, 1.5 mM vanadyl ribocomplexes or 0.15 
U/uL RNaseIN, 0.66 uL for every 140 uL solution, 66 uL for 96-well plate). (Phage dilution 
solution 7ml total: 1050 ul 10x PBS, 52.5 ul 10% Tween20, 52.5 ul 500 mM EDTA, 131 ul 1M 
MgCl2, 10.5 ul 1M glycine, 52.5 mg BSA, 21 ul 10 mg/ml sheared salmon DNA, 52.5 ul 200 
mM Vanadyl ribocomplex, 3ul 4 U/ul RNase IN, ddH2O to 7 ml, do not filter).  
 Maxisorp plate was then washed six times with RNA binding buffer. 100 μL of phage 
supernatant was then transferred from the diluted side of the ELISA plate into both RNA target 
containing wells and the corresponding control wells of the Maxisorp plate. The plate was then 
shaken for 30 minutes at room temperature. 6 more washes were then completed with RNA 
binding buffer. 
 100 uL diluted Anti-M13 antibody/HRP conjugate was then added to each well (diluted 
5000x in RNA binding buffer, 0.5% BSA, 1.5 mM vanadyl ribocomplexes).  Plate was shaken 
for 30 minutes at room temperature. Wells were then washed six times with RNA binding buffer, 
then twice more with RNA binding buffer minus Tween20.  
 Then, 100 uL of the TMB substrate was added and 96 well plate was incubated for 10 
min at room temperature.  Positive wells turned blue within a few minutes. The reaction was 
quenched with 100 μL of 1 M phosphoric acid into each well, at which point the positive wells 
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turned yellow immediately. The absorbance of each well on the 96 well plate was read at 450 nm 
in a plate reader. Positive clones were then sent for DNA sequencing at Genewiz. 
Results of Initial Screening  
 Enrichment values that were obtained from Phage selection for both the VC and FN 
glycine riboswitches were proven to be comparable to enrichment values for P4P6 domain Phage 
Selection (Table 1). This confirmed the functionality and robustness of the YSGR minimal 
codon Fab library for all RNA targets being studied at the initial screening level. DNA 
sequencing of positive clones revealed 17 unique Fabs, all with varied heavy chain and light 
chain CDR regions (Table 2). These unique Fabs were to be expressed and further biochemically 
analyzed. 
 Once Phage ELISA and DNA sequencing were completed, each desired XL-1 blue cell 
colony from the numbered grid was amplified in LB/Amp liquid media. Then, Qiagen miniprep 
DNA harvests were carried out on each culture. This was completed to obtain the plasmid DNA 











Table 1 Results of Phage selection 
RNA Target in Phage Selection Selection round (S = stringent 
conditions) 
Enrichment Reduction Rate 
FNIIItag 2 .77 2.6x107
FNIIItag 3,S 8.12 3.54x107
FNIIItag 4,S 34.42 9.06x104
FNIIItag 5 75.6 2.62x104
VCLD1Tag 2 1.61 8.89x105
VCLD1Tag 3,S 6.84 3.11x107
VCLD1Tag 4 176.97 9.27x104
P4P6 domain 2 11.87 2.92 x106
P4P6 domain 3 107.69 1.31 x106
P4P6 domain 3, S 369.67 4.46 x105
This table shows the results obtained from Phage Display selection for all three RNA targets that 
were screened against the YSGR minimal codon Fab library. An enrichment value of 10 showed 
that nonspecific binders were getting successfully screened out of this Fab library after each 
selection round. Selection was not completed until the necessary enrichment values could be 





Table 2 Sequencing results from Phage ELISA  
RNA Target Fab Name Heavy Chain 
1
Heavy Chain 2 Heavy Chain 3 Light Chain 1 Light Chain 2 Light Chain 3
P4P6 8
YGYRS YSASGLYRGVPSR GYRSPV NLGSGYI SYRPSSGSTR SYSSRYSYAM
11
SVSSA YSASSLYSGVPSR SYSSPI NLYSSSI SRSPRSGGTS RAAGMSTYGF
VCLD1 24
YRYRS SGAYGLYRGVPSR YRSGLV NVSSSSI GSRSSSGSTG SSYGSRSSAM
25
YRYRS SGAYSLYRGVPYR YSSGLI NFSSGSI GSGPSRGSTS SRSRSRSRAM
26
YRYRS SGAYSLYRGVPSG YRYGLI NFGYSSI SYRSSSGSTG SSSSSRSGAM
27
SGSRS YGASSLYGGVPSR YSYGLL NFRSRYI GSGPSRGYTG GSRYRYGSRGM
29
YSYRS YRASRLYGGVPSR RSSYPV NFSGSSI YGSPGYGRTS SSYGSRSGYAM
30
SGSSY YRASSLSSGVPSR YSSRLL NIYRYGI YGSPGSGRTY RYRYRYRSGL
31
RYRSG SGAYGLYSGVPSR YGSGLI NFRYRSI SRSSRSGRTS SRSGYSSGAL
FNIII 10
GYSYS YGAYRLSRGVPYG YSSGPV NISYGSI SSYSRYGRTY SRSRSSYAM
12
SRYRY RSASSLSSGVPSY YSYRLI NIGSRSI SGSSRYGGTY SGSGSSSRYGM
14
YGSGY SGASGLSGGVPSG SYRYPF NVSGSRI SGSSGYGGTS SRSRYSYRYGL
15
GYSYS YGAYRLYGGVPSR SSRSLV NISSYSI SRSPRSGRTS YRYRSGSGL
16
YSSRY YGAYGLYRGVPYR SYSYPI NLGYRYI SGSSGSGSTY GSSYSYRYAF
17
SSRSR YSASGLSRGVPSR YRYRPF NFRSSYI YRSPRSGRTY GSGSRYRGM
18
GYGSR YSASRLSRGVPSS YSYSLL NFSSGYI YGSPSSGRTS SSYRSRYGAM
This table shows the amino acid sequences specific to each Fab. DNA sequencing was 
completed to detect if any duplicates of Fabs were positively isolated from this Fab library, and 
identify the true number of unique Fab clones. Information such as this gave insight on CDR 
region amino acid specificity for the glycine riboswitch. Each column on this table corresponds 
to a CDR region: three light chain CDRs and three heavy chain CDRs.  
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Expression and Biochemical Analysis of Fabs of Interest 
 Each sequenced and unique Fab was expressed and purified as a soluble protein in large 
quantities. The binding affinity and specificity of each Fab for their respective RNA target was 
then characterized by native gel shift assay and dot blot assay. Biochemical assays such as these 
were helpful in determining the potential for a Fab to be a crystallization chaperone, and allowed 
for direct comparison of Fabs to other Fabs yielded from this library (21).  
Materials and Methods for Expression and Purification of Fabs of Interest 
 The following experimental procedures were carried out to express each selected Fab as a 
soluble protein. First, the single stranded DNA template was obtained from the harvested and 
sequenced double stranded DNA that was specific to each Fab. Then, a primer with a stop codon 
was annealed to the template DNA strand which was specific for each Fab. With the subsequent 
annealed DNA product, a heat-shock transformation into 34-B8 strain e.coli was then completed, 
and the resultant cells were grown on an LB/AMP agar plate. The DNA of interest which was 
contained in the 34-B8 cells was amplified via Colony Polymerase Chain Reaction, and 
confirmed by an agarose gel ran at 100V. After further culture amplification, the individual Fab 
proteins were then harvested from culture and purified via immunoaffinity, and ion affinity 
chromatography.  
Biochemical Assays for Characterization of Purified Fabs as Soluble Proteins 
 Once the Fabs were expressed and purified as soluble proteins, then they were analyzed 
for their specificity in binding to their RNA target. This was completed by electrophoretic 
mobility shift assays (EMSA) of the Fab-RNA samples. For the Fabs that proved to be specific-
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RNA target binders as soluble proteins, their binding affinity was then quantified. This was 
completed by dot blot assay.  
 EMSA materials and methods 
 First, the RNA target was folded to its native tertiary structure under the following 
conditions: 0.5 ul 40 uM RNA was added, 6.625 ul 10 mM Tris was added, 7.5 min incubation at 
95ºC, then 2 mins at 50ºC, 1 ul 100 mM MgCl2 was then added, 0.375ul 4M NaCl was added, 1 
ul 0.1M glycine was added, 50ºC for 20 mins, then room temperature for 10 mins. Then the Fab 
protein was added. 
  The last 30min room temperature incubation was carried out just after 0.5 ul of 40 uM of 
Fab was added, this was to allow time for the Fab proteins to complex with their RNA targets 
properly before the gel was ran. The assays were carried out immediately after this Fab-RNA 
complexation time was complete.  
 To run each sample in the native gel, 2 ul of 5x native gel loading dye  was added to each 
sample (625 ul 80% glycerol, 1 mg xylene, cyanol to final concentration of 0.1%, 375 ul 
ddH2O).  Samples were then ran on a 6% native gel (10 ml 10x TB, 29:1 
acrylamide:bisacrylamide, 5 mM MgCl2, 5 mM glycine, 74.5 ml ddH2O, filter through 0.22 um 
filter). The running buffer was for this assay was 100 ml 10x TB(890mM Tris, 890mM Boric 
Acid, H2O), 5 ml 1 M MgCl2, and the gel was run at a constant 120 V for 40 min. The gel was 




Dot blot assay materials and methods 
 Dot blot assays were completed on each of the soluble Fabs, which demonstrated 
specificity for their RNA target. This assay was completed to establish the binding affinity 
between each 
32
P labeled RNA target and its specific Fab protein.  
For the dot blot assay, 50 ul of each of the following concentrations of each Fab was 
made: 20 uM, 10 uM, 5 uM, 2.5 uM, 1.25 uM, 0.625 uM, 0.3125 uM, 0.156 uM, 78 nM, 39 nM, 
and the dilutions were done in 1x PBS in a 96 well plate.  The nitrocellulose and hybond 
membranes were equilibrated in PEM/glycine1 buffer (1x PBS, 0.1 mM EDTA, 10mM MgCl2, 
10 mM glycine).  
 Each radiolabeled RNA target was folded to its native teriary structure with the 
following conditions just before the dot blot assays were carried out. For one 96 well plate, 
~650kcpm worth of radiolabeled RNA target was used, and it was diluted with 4546 uL 
PEM/glycine1 buffer in a 15 ml falcon tube and incubated for 10 min at 50°C. Then the falcon 
tube with diluted RNA was incubated at room temperature for 10 min. Then, 2 uL of RNase IN 
was added, and 130 μL 40 mg/mL Heparin was added. 
Then, Fab and RNA were incubated for comlpexation: 4 ul of each Fab dilution from 
above was aliquoted into a new 96 well plate. The first and last columns were left empty. 36 ul 
of the folded RNA sample was then transferred to each well. The 96 well plate was then covered 
with sealing tape and shaken gently for 30 min at room temperature.  
Then, 100 μL of cold PEM/glycine1 was added to five wells on the dot-blot apparatus.  
As soon as all five solutions were filtered through the membrane, 40 μL of the Fab-RNA samples 
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from above were transferred to the corresponding wells on the dot-blot apparatus from the 96 
well plate. Pipette tips were then changed and the samples were allowed to fully drain through 
both membranes in each of the wells by vacuum. Then, 100 μL of cold PEM/glycine1 was added 
to the same five wells on the dot-blot apparatus. These steps were repeated for the rest of the 
samples. The membranes were developed in a Phosphor Imager cassette. Then, the Phosphor 
Image as scanned the next day by imageQuant software and the resultant data was analyzed in 
Kaliedograph. Each Fab was assayed in duplicate. Results of Biochemical Fab characterization 













Results of Biochemical Characterization of Each Selected Fab 
Results of the EMSA 
 Native gel shift assays were completed for the unique Fabs identified by phage ELISA 
and sequencing. Each selected Fab was assayed in complex with its cognate RNA target that it 
bound during the initial screening. Several Fabs showed RNA target specificity, although many 
Fabs did not. During the initial screening process each Fab was expressed on the coat of a phage 
particle, and this was in contrast to each Fab existing as a soluble entity after the expression. 
Thus this assay was used to reestablish the functionality of each Fab after expression to a soluble 
protein.  
 Of all Fabs that were expressed, the Fabs which demonstrated RNA target specificity for 
the P4P6 RNA target were Fabs 8 and 11. The Fabs which proved RNA target specificity for the 
VCLD1 RNA target were Fabs 29 and 30. Finally, the only Fab which proved RNA target 
specificity for the FNIII target was Fab 16. Target specificity was demonstrated by an upwards 
















Results of the EMSA are shown here. A) Fab 29 and Fab 30 demonstrated specificity or their 
VCLD1 RNA target. B) Fab 16 demonstrated specificity or its FNIII RNA target. C) Fab 8 and 
Fab 11 demonstrated specificity or their P4P6 RNA target.  
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Results of the Dot Blot Assays 
 Dot Blot Assays were carried out on each Fab that demonstrated its functionality. Of the 
selected Fabs that were assayed via Dot Blot, nanomolar Kd values were achieved for all Fabs 
with their substituent RNA targets (Table 3).  Fabs 8 and 11 for the P4P6 RNA target bound the 
tightest, and this was expected as P4P6 was used because it has already demonstrated that it can 
be effectively targeted by Fab proteins (1). Additionally, selected Fabs that were specific for the 
VCLD1 and FNIII RNA targets have demonstrated comparable Kd values to that of the P4P6 
Fabs. This has indicated the true robustness of the YSGR minimal codon Fab library (fig 7). 
 Since Fab 29 and Fab 30 demonstrated satisfactory binding affinities, these Fabs were 
taken a step further. These Fabs were raised against the VCLD1 riboswitch, and when a mutation 
was engineered into the VCLD1, it was hypothesized that this mutation should have decreased 
the binding affinity of Fab 29 and Fab 30 for their target. The results of this experiment are 










Table 3 Kd Values for each Fab 
Fab Name RNA Target Kd (nM) 
2 P4P6 56.51 
8 P4P6 52.56 
11 P4P6 20.13 
16 FNIII 159.92 
29 VCLD1 37.54 
30 VCLD1 21.69 
29 VCLD2 158.34 
30 VCLD2 101.18 
This table shows the nanomolar Kd values that were obtained for each Fab when binding to their 
cognate RNA. By this data, the functionality of our YSGR minimal codon Fab library was 
proven to be robust and functional. For the VC glycine riboswitch, a mutation was made to the 
leader sequence that increased the Kd. This demonstrated that Fab 29 and Fab 30 make specific 
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These were the binding curves which were quantified in kaliedagraph and used to extrapolate the 








 The minimal codon design of this Fab library proved to be sufficient for RNA binding. 
This was confirmed by a library performance against all three RNA targets that was of equal 
magnitude. A minimal codon design within a Fab library has been proven here to be successful 
for enriching Fabs with RNA-specific residues in CDRs. This minimal codon design paired with 
the phage display initial screening process can be viewed as a model system for obtaining anti-
RNA antibodies which can then be used for a variety of clinical and biomedical applications. 
 After biochemical analysis, five Fab proteins have been identified as possible crystal 
chaperones. This biochemical analysis has indicated that their binding affinities and specificities 
are sufficient for potential downstream applications. This analysis has also further confirmed that 
a minimally designed Fab library can yield functional Fab proteins. 
 This project has demonstrated that it is possible to obtain specific RNA-binding 
antibodies by anti-RNA library designs and phage display screening. Anti-RNA antibodies have 
many applications including their use to identify novel RNA disease markers within the cell, 
capabilities in RNA immunoprecipitations, and capabilities in visualization of RNA. 
Furthermore, the success of this Fab library with only four amino acid codons at the RNA 
binding interface greatly improved our understanding of the minimal requirements needed for 
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